Cover Image

A Systematic Review of Screening Tests for Chronic Kidney Disease: An Accuracy Analysis

Fatemeh Keshvari-Shad, Sakineh Hajebrahimi, Maria Pilar Laguna Pes, Alireza Mahboub-Ahari, Mohammad Nouri, Farshad Seyednejad, Mahmood Yousefi

This systematic review was conducted to assess the diagnostic accuracy of chronic kidney disease screening tests in the general population. MEDLINE, EMBASE, Web of Science, Scopus, The Cochrane Library and ProQuest databases were searched for English-language publications up to November 2016. Two reviewers independently screened studies and extracted study data in standardized tables. Methodological quality was assessed using the QUADAS-2 tool. Sensitivity and specificity of all available screening methods were identified through included studies. Ten out of 1349 screened records included for final analysis. Sensitivities of the dipstick test with a cutoff value of trace were ranged from 37.1% to 69.4% and specificities from 93.7% to 97.3% for the detection of ACR>30 mg/g. The diagnostic sensitivities of the UAC>10 mg/dL testing was shown to vary from 40% to 87%, and specificities ranged from 75% to 96%. While the sensitivities of ACR were fluctuating between 74% and 90%, likewise the specificities were between 77% and 88%. Sensitivities for C-G, Grubb and Larsson equations were 98.9%, 86.2%, and 70.1% respectively. In the meantime the study showed specificities of 84.8%, 84.2% and 90.5% respectively for these equations. Individual studies were highly heterogeneous in terms of target populations, type of screening tests, thresholds used to detect CKD and variations in design. Results pointed to the superiority of UAC and dipstick over the other tests in terms of all parameters involved. The diversity of methods and thresholds for detection of CKD, necessitate considering the cost parameter along with the effectiveness of tests to scale-up an efficient strategy. [GMJ.2020;9:e1573]

Chronic Kidney Disease; Screening; Sensitivity; Specificity; Systematic Review

Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS et al. Global prevalence of chronic kidney disease-a systematic review and meta-analysis. PloS one. 2016;11(7):e0158765.

https://doi.org/10.1371/journal.pone.0158765

PMid:27383068 PMCid:PMC4934905

Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. The Lancet Global Health. 2016;4(5):e307-e19.

https://doi.org/10.1016/S2214-109X(16)00071-1

Essue BM, Wong G, Chapman J, Li Q, Jan S. How are patients managing with the costs of care for chronic kidney disease in Australia? A cross-sectional study. BMC nephrology. 2013;14(1):5.

https://doi.org/10.1186/1471-2369-14-5

PMid:23305212 PMCid:PMC3698195

Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Annals of internal medicine. 2003;139(2):137-47.

https://doi.org/10.7326/0003-4819-139-2-200307150-00013

PMid:12859163

Jaar BG, Khatib R, Plantinga L, Boulware LE, Powe NR. Principles of screening for chronic kidney disease. Clinical Journal of the American Society of Nephrology. 2008;3(2):601-9.

https://doi.org/10.2215/CJN.02540607

PMid:18032791 PMCid:PMC6631080

Saunders MR, Cifu A, Vela M. Screening for chronic kidney disease. Jama. 2015;314(6):615-6.

https://doi.org/10.1001/jama.2015.9425

PMid:26262800 PMCid:PMC4813784

Powe NR, Boulware LE. Population-based screening for CKD. American Journal of Kidney Diseases. 2009;53(3):S64-S70.

https://doi.org/10.1053/j.ajkd.2008.07.050

PMid:19231763 PMCid:PMC2681232

Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. Jama. 2015;313(8):837-46.

https://doi.org/10.1001/jama.2015.0602

PMid:25710660 PMCid:PMC4410363

Mula-Abed W-AS, Al Rasadi K, Al-Riyami D. Estimated glomerular filtration rate (eGFR): a serum creatinine-based test for the detection of chronic kidney disease and its impact on clinical practice. Oman medical journal. 2012;27(2):108.

https://doi.org/10.5001/omj.2012.23

PMid:22496934 PMCid:PMC3321332

Vassalotti JA, Centor R, Turner BJ, Greer RC, Choi M, Sequist TD. Practical approach to detection and management of chronic kidney disease for the primary care clinician. The American journal of medicine. 2016;129(2):153-62. e7.

https://doi.org/10.1016/j.amjmed.2015.08.025

PMid:26391748

Levey A, Atkins R, Coresh J, Cohen E, Collins A, Eckardt K-U et al. Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney international. 2007;72(3):247-59.

https://doi.org/10.1038/sj.ki.5002343

PMid:17568785

Stevens LA, Levey AS. Current status and future perspectives for CKD testing. American Journal of Kidney Diseases. 2009;53(3):S17-S26.

https://doi.org/10.1053/j.ajkd.2008.07.047

PMid:19231757

Qaseem A, Hopkins RH, Sweet DE, Starkey M, Shekelle P. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians. Annals of internal medicine. 2013;159(12):835-47.

https://doi.org/10.7326/0003-4819-159-12-201312170-00726

PMid:24145991

Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. American Journal of Kidney Diseases. 2014;63(5):713-35.

https://doi.org/10.1053/j.ajkd.2014.01.416

PMid:24647050

Palmer AJ, Valentine WJ, Chen R, Mehin N, Gabriel S, Bregman B et al. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA. Nephrology Dialysis Transplantation. 2008;23(4):1216-23.

https://doi.org/10.1093/ndt/gfn082

PMid:18359872

Bello AK, Nwankwo E, El Nahas AM. Prevention of chronic kidney disease: a global challenge. Kidney International. 2005;68:S11-S7.

https://doi.org/10.1111/j.1523-1755.2005.09802.x

PMid:16108964

Yousefi M, Najafi S, Ghaffari S, Mahboub-Ahari A, Ghaderi H. Comparison of SF-6D and EQ-5D scores in patients with breast cancer. Iranian Red Crescent Medical Journal. 2016;18(5):e23556.

https://doi.org/10.5812/ircmj.23556

Yousefi M, Sheikhrobat B, Najafi S, Ghaffari S, Ghaderi H, Memarzadeh SE et al. Mapping catquest scores onto EQ-5D utility values in patients with cataract disease. Iranian Red Crescent Medical Journal. 2016;19(5):e21928.

https://doi.org/10.5812/ircmj.21928

Levey AS, De Jong PE, Coresh J, Nahas ME, Astor BC, Matsushita K et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney international. 2011;80(1):17-28.

https://doi.org/10.1038/ki.2010.483

PMid:21150873

Polaris JJ, Katz JN. "Appropriate" diagnostic testing: supporting diagnostics with evidence-based medicine and shared decision making. BMC research notes. 2014;7(1):922.

https://doi.org/10.1186/1756-0500-7-922

PMid:25515327 PMCid:PMC4301652

McInnes MD, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: the PRISMA-DTA statement. Jama. 2018;319(4):388-96.

https://doi.org/10.1001/jama.2017.19163

PMid:29362800

Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of internal medicine. 2011;155(8):529-36.

https://doi.org/10.7326/0003-4819-155-8-201110180-00009

PMid:22007046

Lalkhen AG, McCluskey A. Clinical tests: sensitivity and specificity. Continuing Education in Anaesthesia Critical Care & Pain. 2008;8(6):221-3.

https://doi.org/10.1093/bjaceaccp/mkn041

CfRa D. CRD's guidance for undertaking reviews in health care. York Publishing Services Ltd. 2009;32.

Park JI, Baek H, Kim BR, Jung HH. Comparison of urine dipstick and albumin: creatinine ratio for chronic kidney disease screening: A population-based study. PloS one. 2017;12(2):e0171106.

https://doi.org/10.1371/journal.pone.0171106

PMid:28151999 PMCid:PMC5289498

Konta T, Hao Z, Takasaki S, Abiko H, Ishikawa M, Takahashi T et al. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clinical and experimental nephrology. 2007;11(1):51-5.

https://doi.org/10.1007/s10157-006-0458-z

PMid:17384998

Gansevoort RT, Verhave JC, Hillege HL, Burgerhof JG, Bakker SJ, De Zeeuw D et al. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney International. 2005;67:S28-S35.

https://doi.org/10.1111/j.1523-1755.2005.09408.x

PMid:15752236

Jafar TH, Chaturvedi N, Hatcher J, Levey AS. Use of albumin creatinine ratio and urine albumin concentration as a screening test for albuminuria in an Indo-Asian population. Nephrology Dialysis Transplantation. 2007;22(8):2194-200.

https://doi.org/10.1093/ndt/gfm114

PMid:17405790

Chang C-C, Su M-J, Ho J-L, Tsai Y-H, Tsai W-T, Lee S-J et al. The efficacy of semi-quantitative urine protein-to-creatinine (P/C) ratio for the detection of significant proteinuria in urine specimens in health screening settings. SpringerPlus. 2016;5(1):1791.

https://doi.org/10.1186/s40064-016-3389-5

PMid:27795933 PMCid:PMC5063823

Graziani MS, Gambaro G, Mantovani L, Sorio A, Yabarek T, Abaterusso C et al. Diagnostic accuracy of a reagent strip for assessing urinary albumin excretion in the general population. Nephrology Dialysis Transplantation. 2008;24(5):1490-4.

https://doi.org/10.1093/ndt/gfn639

PMid:19037085

Xue N, Zhang X, Teng J, Fang Y, Ding X. A Cross-Sectional Study on the Use of Urinalysis for Screening Early-Stage Renal Insufficiency. Nephron. 2016;132(4):335-41.

https://doi.org/10.1159/000444650

PMid:26959373

Wetmore JB, Palsson R, Belmont JM, Sigurdsson G, Franzson L, Indridason OS. Discrepancies between creatinine-and cystatin C-based equations: implications for identification of chronic kidney disease in the general population. Scandinavian journal of urology and nephrology. 2010;44(4):242-50.

https://doi.org/10.3109/00365591003709450

PMid:20367222

van der Velde M, de Jong PE, Gansevoort RT. Comparison of the yield of different screening approaches to detect chronic kidney disease. Nephrology Dialysis Transplantation. 2010;25(10):3222-30.

https://doi.org/10.1093/ndt/gfq156

PMid:20335273

White SL, Yu R, Craig JC, Polkinghorne KR, Atkins RC, Chadban SJ. Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. American journal of kidney diseases. 2011;58(1):19-28.

https://doi.org/10.1053/j.ajkd.2010.12.026

PMid:21411199

Moyer VA. Screening for chronic kidney disease: US Preventive Services Task Force recommendation statement. Annals of internal medicine. 2012;157(8):567-70.

https://doi.org/10.7326/0003-4819-157-8-201210160-00533

PMid:22928170

Levey AS, Eckardt K-U, Tsukamoto Y, Levin A, Coresh J, Rossert J et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney international. 2005;67(6):2089-100.

https://doi.org/10.1111/j.1523-1755.2005.00365.x

PMid:15882252

Kellum JA, Bellomo R, Ronco C. Definition and classification of acute kidney injury. Nephron Clinical Practice. 2008;109(4):c182-c7.

https://doi.org/10.1159/000142926

PMid:18802365

Arici M. Clinical assessment of a patient with chronic kidney disease. Management of Chronic Kidney Disease. Springer; 2014. p. 15-28.

https://doi.org/10.1007/978-3-642-54637-2_2

Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney international. 2011;80(12):1258-70.

https://doi.org/10.1038/ki.2011.368

PMid:21993585

Fisher H, Hsu C-y, Vittinghoff E, Lin F, Bansal N. Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio with complications of CKD: a cross-sectional analysis. American Journal of Kidney Diseases. 2013;62(6):1102-8.

https://doi.org/10.1053/j.ajkd.2013.07.013

PMid:24041612 PMCid:PMC3840083

Sam R, Shaykh M, Pegoraro A, Khalili V, Hristea I, Singh A et al. The significance of trace proteinuria. American journal of nephrology. 2003;23(6):438-41.

https://doi.org/10.1159/000074535

PMid:14583662

Patel HP. The abnormal urinalysis. Pediatric Clinics. 2006;53(3):325-37.

https://doi.org/10.1016/j.pcl.2006.02.004

PMid:16716783

Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney international. 2003;63(4):1468-74.

https://doi.org/10.1046/j.1523-1755.2003.00868.x

PMid:12631363

Morris R, Riley R, Doug M, Deeks J, Kilby M. Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis. Bmj. 2012;345:e4342.

https://doi.org/10.1136/bmj.e4342

PMid:22777026 PMCid:PMC3392077

Wahbeh AM, Ewais MH, Elsharif ME. Comparison of 24-hour urinary protein and protein-to-creatinine ratio in the assessment of proteinuria. Saudi Journal of Kidney Diseases and Transplantation. 2009;20(3):443.

Wu H-Y, Peng Y-S, Chiang C-K, Huang J-W, Hung K-Y, Wu K-D et al. Diagnostic performance of random urine samples using albumin concentration vs ratio of albumin to creatinine for microalbuminuria screening in patients with diabetes mellitus: a systematic review and meta-analysis. JAMA internal medicine. 2014;174(7):1108-15.

https://doi.org/10.1001/jamainternmed.2014.1363

PMid:24798807

Nahas ME. The global challenge of chronic kidney disease. Kidney international. 2005;68(6):2918-29.

https://doi.org/10.1111/j.1523-1755.2005.00774.x

PMid:16316385

Komenda P, Ferguson TW, Macdonald K, Rigatto C, Koolage C, Sood MM et al. Cost-effectiveness of primary screening for CKD: a systematic review. American Journal of Kidney Diseases. 2014;63(5):789-97.

https://doi.org/10.1053/j.ajkd.2013.12.012

PMid:24529536

Ferguson TW, Tangri N, Tan Z, James MT, Lavallee BD, Chartrand CD et al. Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective. Kidney international. 2017;92(1):192-200.

https://doi.org/10.1016/j.kint.2017.02.022

PMid:28433383

Flood D, Garcia P, Douglas K, Hawkins J, Rohloff P. Screening for chronic kidney disease in a community-based diabetes cohort in rural Guatemala: a cross-sectional study. BMJ open. 2018;8(1):e019778.

https://doi.org/10.1136/bmjopen-2017-019778

PMid:29358450 PMCid:PMC5781190

Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D et al. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the US Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Annals of internal medicine. 2012;156(8):570-81.

https://doi.org/10.7326/0003-4819-156-8-201204170-00008

Samal L, Linder JA. The primary care perspective on routine urine dipstick screening to identify patients with albuminuria. Clinical journal of the American Society of Nephrology. 2012:CJN. 12681211.

https://doi.org/10.2215/CJN.12681211

PMid:22917702

Parikh R, Mathai A, Parikh S, Sekhar GC, Thomas R. Understanding and using sensitivity, specificity and predictive values. Indian journal of ophthalmology. 2008;56(1):45.

https://doi.org/10.4103/0301-4738.37595

PMid:18158403 PMCid:PMC2636062

Van Stralen KJ, Stel VS, Reitsma JB, Dekker FW, Zoccali C, Jager KJ. Diagnostic methods I: sensitivity, specificity, and other measures of accuracy. Kidney international. 2009;75(12):1257-63.

https://doi.org/10.1038/ki.2009.92

PMid:19340091

Leeflang MM, Rutjes AW, Reitsma JB, Hooft L, Bossuyt PM. Variation of a test's sensitivity and specificity with disease prevalence. Canadian Medical Association Journal. 2013:cmaj. 121286.

https://doi.org/10.1503/cmaj.121286

PMid:23798453 PMCid:PMC3735771

Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal statistical society: series B (Methodological). 1995;57(1):289-300.

https://doi.org/10.1111/j.2517-6161.1995.tb02031.x

Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: a cost-effectiveness analysis. Jama. 2003;290(23):3101-14.

https://doi.org/10.1001/jama.290.23.3101

PMid:14679273

Refbacks

  • There are currently no refbacks.